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The annual meeting of the European Association of Cardiovascular Imaging, EuroEcho-Imaging, was held in Seville, Spain, in December 2015.
In the present paper, we present a summary of the ‘Highlights’ session.
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Introduction
The nineteenth annual scientific meeting of the European Associ-
ation of Cardiovascular Imaging (EACVI), EuroEcho-Imaging 2015,
was held in Seville, Spain. The main themes were ‘cardiomyopathies’
and ‘early diagnosis of cardiovascular disease’. The meeting was a
great success with a high number of participants (.3100 delegates)
and over 1100 abstracts and 150 clinical cases submitted. Overall,
126 abstracts or clinical cases were accepted as oral presentation,
and 54 moderated posters were presented. Of note, the preferred
topics regarding abstracts submission were ‘valvular heart diseases’,
‘cardiomyopathies’, ‘tissue Doppler and speckle tracking’, ‘systemic
disease’, and ‘assessment of systolic function’.
On the last day of the meeting, the ‘Highlights’ session wrapped
up the event with a summary of the most relevant abstracts
presented throughout the congress. A short report of this session
is presented below.
Heart failure
B-lines evaluated by lung ultrasound are a sonographic sign of pul-
monary interstitial oedema, which can be detected in patients
with increased extravascular lung water, a well-known determinant
of prognosis in heart failure (HF).1 A prospective cohort of 89 pa-
tients admitted to a cardiology department for dyspnoea and/or
clinical suspicion of HF was enrolled and followed up for 6 months.
B-lines were evaluated with a cardiac probe on the anterolateral
chest, at admission (T0) and at discharge. Feasibility of B-lines assess-
ment was excellent (100%), and the time required was,5 min in all
cases. Average B-lines significantly decreased from T0 to discharge
(from 53+ 48 to 23+ 23, P, 0.0001). The 6-month event-free
survival was significantly better in patients with lower number of
B-lines (P, 0.0001) and on multivariate analysis. A high number
of B-lines (i.e. .15) (hazard ratio ¼ 10.3, 95% confidence interval:
2.3–45.6) was a powerful independent predictor of impaired out-
come, stronger than any other echocardiographic or clinical
parameters.
In regard to RV function assessment using echocardiography, there
is no consensus on the most appropriate strain parameter. In 103 pa-
tients, global longitudinal strain (RV-GLS) and free wall longitudinal
strain (FWLS)2 were compared regarding event-free survival using
Kaplan–Meier analysis. Patients with RV-GLS . 217.3% showed
lower event-free survival rate (P, 0.001), and this seems to depict
better prognostic value than FWLS. In multivariate analysis including
both strain parameters, only RV-GLS. 217.3% was associated with
outcome.
Left ventricular (LV) pressure–strain loops (PSLs) have been vali-
dated as a non-invasive index of myocardial performance and com-
pared with FDG-PET.3 Regional LV pressure longitudinal strain
loops allow the assessment of global and regional myocardial perform-
ance. Their relationship with LV dyssynchrony provides a window for
a better understanding of LV mechanics. Also, 3-dimensional (3D)
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echocardiography and particle image velocimetry (Echo-PIV) were
performed for different biventricular pacing settings (Figure 1).4 Flow
force angle (FFA) by Echo-PIV reflected the dominant direction of
blood flow momentum (08 when flow forces are parallel with LV
long axis, and 908 when flow forces are transversal). Accordingly, a
lower FFA would reflect more efficient blood flow dynamics within
the LV. FFA by Echo-PIV was significantly lower for BIV vs. CRT-OFF,
and also for MPP vs. BIV. 3DE and Echo-PIV enabled to identify an
acute improvement in LV systolic function and blood flow dynamics
during MPP.5
Patients with severe HF and ejection fraction ≤35% represent a
heterogeneous group. Strain parameters derived from LV speckle
tracking echocardiography (STE) could reflect residual functional
capacity and haemodynamic compromise better than ejection frac-
tion (EF). LV GLS was better correlated with 6-min walking test
(MWT) distance and brain natriuretic peptide (BNP) levels than
LV ejection fraction. In multiple linear regression analysis, GLS
emerged as a determinant of 6-MWT distance and BNP level.6
In HF with preserved ejection fraction (HFpEF), the exercise in-
tolerance is determined by multiple mechanisms. In a study from
Poland, peak VO2 and exertional reserve were less impaired in pa-
tients with normal vs. patients with abnormal E/e′ ratio.7 Independ-
ent correlates of peak VO2 were exertional E/e′ ratio and LV GLS.
Nevertheless, there is still no consensus for the diagnosis of HFpEF.8
Current studies recommend stress echocardiography protocols,
but single standard peak or timing measurements are limited due
to the complexity of this disease. The contribution of a combined
analysis of multiple myocardial velocity patterns and their relative
relevance for the characterization of HFpEF were investigated.
The characterization of HFpEF is improved by a combined analysis
of multiple velocity traces from stress echo studies using machine
learning. The method suggests additional features of interest to be
used in clinical diagnosis.
Valvular heart disease
The majority of abstracts selected this year in the valvular heart
disease section of the highlights session investigated the impact
and relationship between concomitant valve regurgitation (i.e. MR
or TR) and transcatheter aortic valve intervention (TAVI). Indeed,
the presence and severity of TR, as well as RV function, were retro-
spectively assessed in 519 patients with TAVI.9 Only 11% of patients
were found with ≥moderate TR at the time of TAVI and TAPSE, and
not TR severity was an independent predictor of mortality following
TAVI. However, in around 50% of patients, TR did not improve after
TAVI, and persistent TR at 6 months was independently associated
with reduced survival. Furthermore, the lack of improvement of TR
following TAVI was mainly determined by older age, female gender,
history of atrial fibrillation, and pulmonary hypertension.
Discrepant results were reported regarding the impact of MR on
outcome following TAVI. A study by Del Val Martin et al.10 reported
the prospective analysis of 90 patients with TAVI. More than mod-
erate MR was found in 24% of patients before TAVI and decreased
after TAVI (8%), without statistically significant difference between
patients with significant vs. non-significant MR improvement in
terms of 2-year clinical event (26.8 vs. 24.3%). Conversely, Szymans-
ki et al.11 have reported a larger population of 381 patients with
TAVI in whom both significant pre-TAVI and post-TAVI MR were
associated with significantly reduced 1-year survival.
The role of LV GLS in patients with severe aortic stenosis (AS) and
preserved LV ejection fraction is growing. In 582 patients included in a
multicentre study,12 GLS. 213.75%, assessed using 2D STE, was a
significant determinant of reduced 2-year survival (93 vs. 84%, P ¼
0.001). In addition, after adjustment of confounders, impaired LV
GLS was associated with around 2.5-fold increase in risk of death
(hazard ratio ¼ 2.47, 95% confidence interval: 1.04–5.90, P ¼
0.041). Patients with atrial fibrillation (AF) may develop atrial
functional mitral regurgitation (AFMR) despite normal ventricular
function. Tang et al.13 performed a real-time 3D echocardiographic
study evaluating 3D mitral annular geometry and dynamics in AF pa-
tients. They aimed to identify factors, including LA and LV function
parameters, associated with abnormalities of mitral annular dynamics
in AFMR. They found that impaired pre-systolic contraction and sad-
dle shape deepening of mitral annulus may contribute to AFMR. Fur-
thermore, compared with patients without AFMR, those with AFMR
depicted significantly lower left atrial peak strain (20+8 vs. 12+6%,
P, 0.0001) and LV basal circumferential strain (219+5 vs.216+
3%, P ¼ 0.002). Consequently, their data suggest that the loss of pre-
systolic annular deformation is associated with impaired contractile
function of the left atrium and basal LV myocardium.
Histotripsy is a cavitation-based therapy (i.e. using mechanical ef-
fect) that uses very short, high-pressure ultrasound pulses to gener-
ate a dense, energetic, lesion-producing bubble cloud (Figure 2). A
pilot, proof-of-concept study was conducted by Villemain et al.14
in which they applied histotripsy for non-invasive mitral valve chord-
al cutting both in vitro using explanted sheep heart (n ¼ 10) and in
vivo on sheep beating heart after sternotomy (n ¼ 7). The in vitro
study showed excellent feasibility with 100% of chordal cut in an
average time to complete section of 5.5 min (range: 3–9 min). Simi-
lar results were reported in the in vivo study in terms of feasibility
but with longer average procedure time (21 min). Of interest, the
Figure 1 Example of the left ventricular fluid dynamics assessed
by Echocardiographic Particle Image Velocimetry (Echo-PIV). This
approach looks very promising to optimize the mode of pacing in
patients implanted with a bi-ventricular pace maker and with a left
ventricular multi-pole lead.
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sectioned chordae were visible on echocardiography, and mitral
valve coaptation remained normal with no significant MR. Anatom-
ical and histological post-mortem explorations of hearts confirmed
the section of the chordae and only one additional anatomic lesion
on LV lateral wall. The authors concluded that histotripsy may
achieve successful mitral valve chordal cutting and that this
technique may open the door to the non-invasive treatment of
functional MR.
3-Dimensionnal echocardiography
A patient-specific, quantitative model of the complex 3D mitral
valve (MV) geometry and dynamics might improve pathophysiologic
insight and enhance therapeutic efficacy by predicting the effect of
interventions. A patient-specific numerical model of the MV appar-
atus based on 3D transoesophageal echocardiography (3D-TEE)
was developed and validated in predicting MV dynamics in different
haemodynamic loading conditions (Figure 3).15 The model realistic-
ally predicted opening and closure of the MV leaflets in all datasets.
Comparison of the predicted mid-systolic closure vs. real-time
3D-TEE imaging showed good accuracy with an average prediction
error (root mean square) ranging from 1.4 to 2.9 mm. Furthermore,
the position of the coaptation line was predicted with an average er-
ror ranging from 0.6 to 2.0 mm. Point-to-point error between
predicted and real-time leaflet position was the highest in the inter-
trigonal area due to bulging in the simulated leaflets. 3D-TEE-based
patient-specific numerical MV modelling allows a realistic prediction
of valvular dynamics in physiological loading conditions.
The analysis of the mitral annulus (MA) 3D geometry was per-
formed and compared between 71 patients with primary mitral re-
gurgitation (MR) due to fibroelastic deficiency and controls. Patients
were classified according to the extent of MV disease, i.e. limited MV
disease ≤3 scallops affected vs. extensive MV disease, i.e. ≥4 scal-
lops involved (Barlow-like).16 The MA diameters and the non-planar
angles (NPA) were measured in five systolic moments throughout
systole. The parameters describing MA non-planarity were signifi-
cantly different between patients with fibroelastic deficiency,
Barlow-like disease and normal subjects mostly in the late part of
systole suggesting the importance of non-planar angle changes in
the pathophysiology of different types of MV prolapse.
The study of Aquila et al.17 aimed to evaluate the feasibility and
accuracy of a full-automated software for 3D TEE assessment of
MV in 45 patients with severe primary and secondary MR. The soft-
ware correctly identified anatomic differences in primary vs. sec-
ondary MR. Furthermore, the diameter enlargement in diastole
suggested that in the primary MR, the annulus has a dynamic behav-
iour that is profoundly different from the non-dynamic annulus
observed in secondary MR.
Figure 2 Histotripsy application for mitral chordal cutting. (A) Description of chordal cutting mechanism. (B) Histotripsy device. (C ) Two-
chamber epicardial echocardiography imaging. Left, before chordal cutting. Centre, during the therapy with cavitation bubbles observed on
the basal chordae of the anterior leaflet (white arrow). Right, after therapy with basal chordae prolapsing into the left atrium (with arrow).
(D) En-face view of the explanted mitral valve apparatus. We observed the section of the basal chordae arising from the anterior leaflet and
inserting on the posterior papillary muscle (black arrow).
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Estimation of mitral valve area (MVA) by using the PISA method
with real-time 3D color Doppler echocardiography might circum-
vent the technical limitations of 2D echocardiography planimetry.
In patients with mitral stenosis, the calculation of the flow
convergence volume by 3D and the PISA-derived estimate of
MVA was performed using a semi-automatic dedicated software.
The use of 3D PISA showed the best correlation, followed by pres-
sure half-time, continuity equation, and 2D PISA. Therefore, it was
suggested that MVA estimation using 3D PISA method was feasible
and more accurate than 2D methods.18
Unfortunately, limited data are available regarding 3D STE to
evaluate LV mechanics in neonates. The aims of this study were
to evaluate the feasibility and establish normal values of 3D LV vo-
lumes, ejection fraction, and the four normal strains in 50 healthy
neonates.19 While naturally sleeping, full volume data sets from
the apical window were acquired. Mean indexed LV diastolic, systol-
ic volumes, and ejection fraction were 24.7+ 3.6 mL/m2, 9.2+
1.3 mL/m2, and 63+ 3.7%, respectively. Normal global longitudinal,
circumferential, radial, and tangential 4D strain were 220.9+2.8,
232.4+ 3.1, 44.3+ 3.4, and 239.7+ 3.4%, respectively. The
3D-STE is feasible in newborns without the need for sedation and
allows establishing normal reference values of regional and global
LV 4D strain and volumes.
Cardiovascular magnetic
resonance
Abstracts on cardiovascular magnetic resonance (CMR) imaging
focused mostly on emerging CMR methodology and prognostic
value of established methods.
Native T1 mapping has been used to detect diffuse myocardial
pathologies including oedema and fibrosis. Vieira et al. demon-
strated in 20 adolescents and young adult cancer survivors that
non-contrast CMR T1 mapping can identify subclinical cardiac injury
following anthracycline therapy, which was not detected by stand-
ard LV function assessment.20 They also found changes in pulse
wave velocity (PWV), suggesting that emerging CMR methods are
candidates for future screening of cancer patients.
T1 mapping before and after contrast administration can be used
to quantify the myocardial extracellular volume (ECV), and several
recent studies have indicated that ECV is a marker of interstitial fi-
brosis and infiltration in a wide range of conditions. Although normal
values vary to some extent between previous reports, an ECV of
23–26% is generally considered as normal. Nastase et al. studied
27 consecutive patients with severe AS and 21 patients with severe
aortic regurgitation (AR).21 While native T1 was similar between the
two groups, ECV was elevated in both groups and was higher in pa-
tients with AR (31+ 3%) than in patients with AS (29+4%). These
preliminary results clearly require confirmation in larger studies but
point to the potential of parametric CMR mapping to identify LV re-
modelling in valve disease with the potential to contribute to deci-
sions about the timing of surgery.
Another abstract in aortic valve disease by von Knobelsdorff
et al.22 examined the value of CMR tissue phase mapping in patients
with LV pressure overload at rest and during stress. In this study, 9
patients with hypertensive heart disease, 24 patients with AS, and 41
healthy controls were studied. Hypertensive patients showed lower
peak myocardial velocities in diastole, while those with AS had re-
duced velocities both in diastole and in systole compared with
healthy controls. Furthermore, there was no adaption to isometric
Figures 3 Geometry of the mitral valve (MV) apparatus extrac-
tion from full volume 3D-TEE by manual segmentation of one
end-diastolic frame and transferred into a finite element mesh.
Patient-specific boundary conditions (annular and papillary muscle
position and dynamics) were manually extracted from the 3D-TEE
images for the entire cardiac cycle. Leaflets were modelled as
transversely isotropic hyperelastic material based on prior in vitro
mechanical testing; chordae were modelled as hyper elastic con-
nections between papillary muscles and leaflets. The end-diastolic
finite element mesh, material properties, and boundary conditions
were combined to numerically calculate MV dynamics when apply-
ing a certain haemodynamic load. For validation, datasets from five
normal MVs were prospectively collected during elective percu-
taneous closure procedures of a patent foramen ovale during
which left atrial and ventricular pressures were invasively mea-
sured, and 3D TEE was simultaneously acquired.
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exercise in either of the patient groups, unlike in controls, as an in-
dicator for early functional impairment.
Castillo et al.23 investigated the recently reported ‘splenic switch-
off’ seen during vasodilators stress CMR studies. They showed in a
small study that splenic perfusion was reduced with both adenosine
and dipyridamole but not with dobutamine stress. The authors con-
cluded that splenic perfusion assessment may be used to reduce
false-negative stress CMR studies.
Several abstracts dealt with prognostic CMR markers. Park and
co-workers assessed the use of CMR in the assessment of patients
with TR, making use of the ability of CMR to accurately assess right
ventricular size and function.24 They studied 75 patients in whom se-
vere functional tricuspid regurgitation was the only haemodynamic-
ally significant lesion and who underwent isolated tricuspid valve
surgery. They report that right ventricular ejection fraction, derived
from CMR, was an independent predictor of mortality.
Ramos et al.25 studied 394 patients referred for adenosine perfu-
sion CMR and investigated whether a blunted heart rate response to
adenosine had prognostic implications. Although there were signifi-
cant differences in death on follow-up depending on the heart rate
response in groups divided into tertiles, there was no statistically sig-
nificant difference on multivariate analysis. However, this work sug-
gests that larger studies should be considered to further explore
these relationships.
Congenital heart disease
The congenital heart disease (CHD) programme in 2015 featured
many strong scientific sessions and a variety of abstracts spanning
the whole life cycle from fetal cardiology to longer term outcomes
in adults with single ventricle palliation for complex CHD.
The predominant themes that emerged among the accepted ab-
stracts were aortic dilatation either in patients born with congenital
bicuspid aortic valve (BAV) or with other forms of CHD, most not-
ably Tetralogy of Fallot; multimodality and integrated assessment for
patients with repaired CHD; and assessment and surgical planning
for newborns, children and adults with complex single ventricle
CHD.
In a retrospective study of 81 adults with BAV, Aguiar Rosa et al.26
aimed to identify predictors of aortic dilatation by exploring any re-
lationship between aortic dilation and BAV subtype, transaortic
valve gradient, AR, and/or global circumferential strain (GCS) at
the level of the valve annulus. The commonest BAV pattern seen
was fusion of the right and left coronary cusps in 53% of cases.
This is in general agreement with other abstracts presented at the
meeting.27,28 Age, male gender, and mean aortic pressure gradient
were significantly related to aortic dilatation, predominantly at the
aortic root. Coarctation, systemic hypertension, and GCS at annulus
were not predictive. Importantly, 25 patients with moderate AR
have a significantly higher sinus of Valsalva diameter (34.5+ 5.5
vs. 31.6+ 5.7 mm, P ¼ 0.0195).
Dilatation of the ascending aorta (AAo) is also an important con-
comitant in Tetralogy of Fallot (ToF). Pontnau et al.29 assessed aor-
tic root dilatation and stiffness by CMR imaging in adults with
repaired ToF. In a study of 50 ToF patients and 50 controls, standard
CMR sequences obtained aortic root dimensions; aortic distensibil-
ity and PWV and examined elasticity. Compared with controls,
patients with ToF had significantly decreased distensibility, increased
PWV, impaired LV and RV ejection fraction, and AR was seen more
often. Furthermore, no significant relationship was seen between
age and distensibility, age and PWV, age at repair and stiffness or in-
deed age at surgical repair and aortic dilatation.
Cruz et al.30 used a multimodality approach to assess the preva-
lence and implications of this aortic dilatation, utilizing CMR imaging
to measure aortic dimensions, LV mass, systolic function, and 2D
STE to derive the peak circumferential AAo Strain (CAAS) and
thus calculate the aortic stiffness index. The global peak CAAS
was calculated as the average peak systolic circumferential strain
of the six segments representing the whole circumference of the
AAo in short-axis view. Although systolic, diastolic, and pulse pres-
sures were within normal range, a larger AAo diameter correlated
with higher LV end-diastolic and end-systolic volumes, LV mass, and
lower arterial stiffness (Ea) (r ¼ 20.34, P ¼ 0.03). There was a posi-
tive correlation between the AAo diameter measured by CMR im-
aging and 2D STE-derived aortic stiffness index (r ¼ 0.315, P ¼
0.045). Furthermore, by multivariate analysis, age (b ¼ 0.297, P ¼
0.038) and 2D STE aortic stiffness index (b ¼ 0.289, P ¼ 0.044)
were independent predictors of the AAo diameter. The authors
conclude that a multimodality approach to imaging of the AAo
may unmask an intrinsic aortopathy after ToF repair.
CMR is the established gold standard when assessing RV volume,
RV ejection fraction, and regurgitant fraction (RF). However, CMR is
less available, more resource intensive, and costly compared with
echocardiography. Silva et al.31 used a standardized systematic ap-
proach of 2D transthoracic echocardiography (TTE) and 2D STE
to compare echocardiographic- and CMR-derived indices in the
same patients. RV mid-cavity diameter could be used to accurately
predict RV end-diastolic volume, and the RV GLS showed good lin-
ear correlation with TTE and CMRI parameters of RV function.
Moving on from ToF, several authors addressed the difficult issue
of imaging the single ventricle. Bellsham-Revell et al.32 used TTE be-
fore and after the Hybrid Procedure first-stage surgical palliation
where an unrestrictive interatrial communication is critical. The
most striking echocardiographic feature of atrial restriction was the
change in spectral Doppler waveform from more normal sawtooth
pattern to a notched pulsatile pattern. In the adult with a palliated
Fontan circulation, Castaldi et al.33 used integrated multimodality in-
vestigations to assess cardiac performance. They found that standard
2D echocardiography has limited value for functional evaluation of
single ventricles, but that 3D ejection fraction and speckle tracking
have shown better correlation with VO2max values. NT-pro-BNP le-
vels showed a strong correlation with longitudinal strain and 3D ejec-
tion fraction. Cordina et al.34 looked at echocardiographic predictors
of mortality in this complex group of adults with CHD and a Fontan
circulation. After examining many standard echocardiographic indices
of ventricular performance, they reported that an increased ratio of
the systolic-to-diastolic duration (.1.1) measured using inflow Dop-
pler across the dominant atrioventricular valve was the most import-
ant echocardiographic marker and should be incorporated into
routine clinical assessment.
Finally in the Young Investigator Award—Basic Science oral pres-
entation, Valverde et al.35 presented results from a European multi-
centre assessment of the feasibility and accuracy of 3D printed
models in complex CHD in newborns and children (Figure 4). After
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reporting anatomic and morphologic accuracy compared with
CMR/computed tomography and actual surgical exploration, they
then reported the effect of having 3D printed heart models on sur-
gical decision-making. There was wide acceptance by the involved
cardiologists and cardiac surgeons and suggest that such modelling
may become the elective tool for surgical planning of complex CHD
and may help reducing surgical time and surgical complications.
Nuclear cardiology and cardiac
computed tomography
Single photon emission computed tomography (SPECT) is an estab-
lished approach to detect myocardial ischaemia in patients with
known or suspected coronary artery disease (CAD). There is in-
creasing attention to improve the cost-effectiveness of this
approach. SPECT perfusion studies are commonly based on a
stress-rest protocol. In case of normal stress imaging results, a
rest acquisition could be safely avoided as demonstrated in a large
population of patients with a wide range of pre-test likelihood of dis-
ease by Kitsiou et al.,36 thus lowering radiation exposure, costs, and
exam time. On the other hand, it is known that attenuation artifacts
may induce false-positive stress SPECT results. Lagan et al.37 de-
monstrated that new SPECT scanners, with ECG gating and in-built
CT to correct for diaphragm/breast attenuation, allow to detect less
reversible perfusion defects resulting in lower referral to invasive
coronary angiography, significant cost savings without compromis-
ing patients’ safety.
Nuclear imaging of cardiac innervation by (123)I-metaiodobenzyl-
guanidine (123I-MIBG) is able to assess abnormal cardiac sympathetic
activity in patients with HF and has established prognostic implica-
tions. Rio et al.38 studied 102 patients with HF prior to cardiac
Figure 4 Example of 7.5-year-old boy with dextrocardia double outlet right ventricle, sub aortic ventricular septal defect, and severe pulmonary
stenosis with previous bi-directional cavopulmonary connection. The patient was considered for Fontan completion, but the bi-ventricular repair
was also considered. 3D model helped to exclude the option of biventricular repair due to the small RV size.
Figure 5 Polar maps representing regional left ventricular myocardial innervation (late MIBG uptake, left panel) and perfusion (middle panel).
Mismatch is defined as a myocardial region with reduced late MIBG uptake despite preserved perfusion (right panel).
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resynchronization therapy (CRT). Increased cardiac sympathetic
activity at baseline, as shown by low late heart-to-mediastinum ratio
of 123I-MIBG uptake (,1.5), was associated with larger left ventricu-
lar volumes and worse global longitudinal strain with less improve-
ment of functional parameters at 6 months after CRT. However,
abnormal cardiac sympathetic activity after CRT can be favourably
modulated by high intensity exercise training as Abreu et al.39
demonstrated using the same imaging approach. 123I-MIBG and
myocardial perfusion SPECT imaging, when combined in patients
with HF, provide additional prognostic information. In patients
with LV ejection fraction ,35%, Limeres et al.40 demonstrated
that both inducible ischaemia and a ‘mismatch’ pattern, i.e. lower
123I-MIBG uptake in the presence of preserved perfusion (Figure 5),
were powerful predictors of major adverse cardiovascular events at
35 months.
Detection of inflammation is a recent specific application of nu-
clear imaging. Becoulet et al.41 studied a small series of 17 consecu-
tive patients with suspected inflammatory cardiomyopathies by
18F-FDG positron emission tomography. Six patients had the final
diagnosis of cardiac sarcoidosis (CS), and all had positive PET scans
with distinctive features compared with the seven non-CS patients
with mildly positive PET scans. All patients with positive PET scans
had evidence of late gadolinium enhancement by magnetic reson-
ance in FDG uptake areas, suggesting a true positivity of PET for
the presence of myocardial inflammation.
The clinical use of coronary CT angiography (CCTA) has been
expanded from diagnosis of CAD to prognostic stratification, and
thanks to recent technological advancements, the radiation expos-
ure to the patient has been substantially reduced. Clerc et al.42 fol-
lowed for a median period of 6.1 years, 434 patients studied by
low-dose 64-slice CCTA (mean effective dose 1.7+0.6 mSv). No
major adverse cardiovascular event (MACE) occurred in the 153 pa-
tients with normal coronary arteries at CTA while MACE were re-
gistered in a progressively greater proportion of patients with
non-obstructive, obstructive, or already revascularized coronary le-
sions. Thus, CCTA suggested a warranty period of .6 years for pa-
tients with normal coronaries. Non-obstructive CAD deserves
specific attention since it may be at risk of atherothrombotic events.
In a large population of 761 patients with angina symptoms who
underwent 128-row multislice CCTA, Jug et al.43 demonstrated
that, after adjustment for age, gender, and risk factors, non-
obstructive CAD was associated with a significant increase in the
risk of adverse events, compared with no CAD, with an annual event
rate of 2.8%.
Relevant applications of CT include characterization of cardiac
anatomy before interventional procedures or in structural cardiac
diseases. Pontone et al.44 showed that CT imaging of the left atrium
may improve outcome of radiofrequency catheter ablation of atrial
fibrillation and can now be obtained with an effective dose of ,1
mSv, close to chest X-ray exposure. Celeng et al.45 showed a better
reproducibility of CT angiography to measure aortic root dimen-
sions in 101 twin pairs compared with transthoracic echocardiog-
raphy and found that the heritability of the aortic root geometry
is stronger than it was reported previously. Finally, Van Den Hoven
et al.46 used CT to evaluate the prevalence of partial abnormal pul-
monary venous return (PAPVR) in 90 patients with Turner syn-
drome. A quarter of all Turner patients turned out to have
PAPVR, which was missed before in nearly half of the patients sug-
gesting that pulmonary venous return should be implemented in the
standard imaging protocol of Turner patients.
Conflict of interest: None declared.
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